Baricitinib for Systemic Lupus Erythematosus: A Double-blind, Randomised, Placebo-controlled, Phase 3 Trial (sle-brave-i)

Morand, Eric F; Vital, Edward M; Petri, Michelle; van Vollenhoven, Ronald; Wallace, Daniel J; Mosca, Marta; Furie, Richard A; Silk, Maria E; Dickson, Christina L; Meszaros, Gabriella; Jia, Bochao; Crowe, Brenda; de la Torre, Inmaculada; Dörner, Thomas